Medinotec Inc.
MDNC
$5.00
$0.000.00%
OTC PK
| 05/31/2026 | 02/28/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 45.50% | -28.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 45.50% | -28.18% | |||
| Cost of Revenue | 38.84% | -18.75% | |||
| Gross Profit | 53.02% | -36.51% | |||
| SG&A Expenses | 6.11% | 33.06% | |||
| Depreciation & Amortization | -63.40% | 655.84% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.40% | 5.15% | |||
| Operating Income | 168.47% | -147.80% | |||
| Income Before Tax | 176.35% | -150.32% | |||
| Income Tax Expenses | 93.38% | -246.37% | |||
| Earnings from Continuing Operations | 420.35% | -117.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 420.35% | -117.18% | |||
| EBIT | 168.47% | -147.80% | |||
| EBITDA | 198.16% | -136.76% | |||
| EPS Basic | 373.91% | -123.00% | |||
| Normalized Basic EPS | 164.91% | -167.86% | |||
| EPS Diluted | 373.91% | -123.00% | |||
| Normalized Diluted EPS | 164.91% | -167.86% | |||
| Average Basic Shares Outstanding | 17.51% | -25.60% | |||
| Average Diluted Shares Outstanding | 17.51% | -25.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||